Dovato 50-300 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FG3ZH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,867
Award facts
- Contract value 100% obligated
- $98,866.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $98,866.60 to AmerisourceBergen Drug Corp for the supply of DOVATO 50-300 mg tablets (30-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and was awarded on a non-competitive basis without set-aside designation. Performance will occur at the awardee's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at up to $999,999,999.00 and extends through December 2026. This prime IDC vehicle provides comprehensive pharmaceutical support globally, enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor that holds critical contracts with federal agencies including the Department of Defense and Department of Veterans Affairs. The company demonstrates substantial capacity to fulfill federal medical procurement requirements across multiple therapeutic domains. DOVATO is an antiretroviral medication used in HIV treatment, reflecting the company's role in supplying specialized pharmaceutical products to military and federal healthcare systems. The non-set-aside award indicates the contract was competitively awarded through open competition, consistent with AmerisourceBergen's established track record of meeting federal procurement standards.
Quick answers
Who was awarded contract SPE2DR26FG3ZH?
SPE2DR26FG3ZH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FG3ZH worth?
The government has obligated $98,867 on SPE2DR26FG3ZH.
Is contract SPE2DR26FG3ZH an order under another contract?
Yes. SPE2DR26FG3ZH is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3ZH competed?
The extent of competition for SPE2DR26FG3ZH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award